Psoriasis: Targets and Therapy
Volume 8, 2018 - Issue
Open access
75
Views
8
CrossRef citations to date
0
Altmetric
Review
Spotlight on risankizumab and its potential in the treatment of plaque psoriasis: evidence to date
Álvaro Machado1 Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal, [email protected]
& Tiago Torres1 Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal, [email protected];2 Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal, [email protected]Correspondence[email protected]
Pages 83-92
|
Published online: 13 Nov 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.